Sofinnova Ventures »

Arrivent Biopharma shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2024-06-30 $32M 1.7M 18.55
2024-03-31 $30M 1.7M 17.86

More positions owned by Sofinnova Ventures

Invesco QQQ TR Unit Ser 1 Put Option (QQQ)
Natera (NTRA)
Edwards Lifesciences (EW)
Vera Therapeutics Cl A (VERA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Novo-Nordisk A S Adr (NVO)
Stryker Corporation (SYK)
AstraZeneca Sponsored Adr (AZN)
Intuitive Surgical (ISRG)
Dyne Therapeutics (DYN)
Align Technology (ALGN)
Alnylam Pharmaceuticals (ALNY)
Rapport Therapeutics (RAPP)
Syndax Pharmaceuticals (SNDX)
Elanco Animal Health (ELAN)

View all positions for Sofinnova Ventures

Top funds holding Arrivent Biopharma

Hillhouse Capital Advisors
OrbiMed Advisors
Octagon Capital Advisors
Suvretta Capital Management
Sofinnova Ventures
Novo A/S
Sc China Holding
BlackRock
Vanguard Group
Cormorant Asset Management
Perceptive Advisors
Geode Capital Management
State Street Corporation
Woodline Partners
Charles Schwab Investment Management

View all funds holding Arrivent Biopharma